| Dr Michael Morikawa, AUD | |
|
2115 Wisconsin Ave Nw Ste 202, Washington, DC 20007-2265 | |
| (202) 944-5300 | |
| Not Available |
| Full Name | Dr Michael Morikawa |
|---|---|
| Gender | Male |
| Speciality | Qualified Audiologist |
| Experience | 6 Years |
| Location | 2115 Wisconsin Ave Nw Ste 202, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447746797 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mgmc Llc | 9537073119 | 412 |
News Archive
Public health researchers have analyzed soda consumption data in order to characterize people's exposure to a potentially carcinogenic byproduct of some types of caramel color. Caramel color is a common ingredient in colas and other dark soft drinks. The results show that between 44 and 58 percent of people over the age of six typically have at least one can of soda per day, possibly more, potentially exposing them to 4-methylimidazole (4-MEI), a possible human carcinogen formed during the manufacture of some kinds of caramel color.
The authors assert that cesarean section carries an independent risk in multiple births. They defend the benefits of vaginal delivery and promote the use of cesarean section as an option
UCLA researchers examining outcomes for advanced heart-failure patients over the past two decades have found that, coinciding with the increased availability and use of new therapies, overall mortality has decreased and sudden cardiac death, caused by the rapid onset of severe abnormal heart rhythms, has declined.
Gonadotropin-Releasing Hormone (GnRH) agonists, a class of medications primarily used to treat men with prostate cancer, have been associated with a small increased risk for diabetes, heart attack, stroke, and sudden death in men treated with one of the medications, according to a preliminary and ongoing analysis of several studies by the U.S. Food and Drug Administration.
Most physicians are treating the symptom of headache using medication. Patients often receive temporary relief from the medication but it does not deal with the cause of the headache. The drug companies are sponsoring research programs to test their drugs in conjunction with most "Headache Facilities."
› Verified 6 days ago
| Provider Name | Mgmc Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1891797148 PECOS PAC ID: 9537073119 Enrollment ID: O20031220000056 |
News Archive
Public health researchers have analyzed soda consumption data in order to characterize people's exposure to a potentially carcinogenic byproduct of some types of caramel color. Caramel color is a common ingredient in colas and other dark soft drinks. The results show that between 44 and 58 percent of people over the age of six typically have at least one can of soda per day, possibly more, potentially exposing them to 4-methylimidazole (4-MEI), a possible human carcinogen formed during the manufacture of some kinds of caramel color.
The authors assert that cesarean section carries an independent risk in multiple births. They defend the benefits of vaginal delivery and promote the use of cesarean section as an option
UCLA researchers examining outcomes for advanced heart-failure patients over the past two decades have found that, coinciding with the increased availability and use of new therapies, overall mortality has decreased and sudden cardiac death, caused by the rapid onset of severe abnormal heart rhythms, has declined.
Gonadotropin-Releasing Hormone (GnRH) agonists, a class of medications primarily used to treat men with prostate cancer, have been associated with a small increased risk for diabetes, heart attack, stroke, and sudden death in men treated with one of the medications, according to a preliminary and ongoing analysis of several studies by the U.S. Food and Drug Administration.
Most physicians are treating the symptom of headache using medication. Patients often receive temporary relief from the medication but it does not deal with the cause of the headache. The drug companies are sponsoring research programs to test their drugs in conjunction with most "Headache Facilities."
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Morikawa, AUD 1811 Vernon St Nw Apt 204, Washington, DC 20009-1253 Ph: (540) 335-5402 | Dr Michael Morikawa, AUD 2115 Wisconsin Ave Nw Ste 202, Washington, DC 20007-2265 Ph: (202) 944-5300 |
News Archive
Public health researchers have analyzed soda consumption data in order to characterize people's exposure to a potentially carcinogenic byproduct of some types of caramel color. Caramel color is a common ingredient in colas and other dark soft drinks. The results show that between 44 and 58 percent of people over the age of six typically have at least one can of soda per day, possibly more, potentially exposing them to 4-methylimidazole (4-MEI), a possible human carcinogen formed during the manufacture of some kinds of caramel color.
The authors assert that cesarean section carries an independent risk in multiple births. They defend the benefits of vaginal delivery and promote the use of cesarean section as an option
UCLA researchers examining outcomes for advanced heart-failure patients over the past two decades have found that, coinciding with the increased availability and use of new therapies, overall mortality has decreased and sudden cardiac death, caused by the rapid onset of severe abnormal heart rhythms, has declined.
Gonadotropin-Releasing Hormone (GnRH) agonists, a class of medications primarily used to treat men with prostate cancer, have been associated with a small increased risk for diabetes, heart attack, stroke, and sudden death in men treated with one of the medications, according to a preliminary and ongoing analysis of several studies by the U.S. Food and Drug Administration.
Most physicians are treating the symptom of headache using medication. Patients often receive temporary relief from the medication but it does not deal with the cause of the headache. The drug companies are sponsoring research programs to test their drugs in conjunction with most "Headache Facilities."
› Verified 6 days ago
Sheela L Stuart, PHD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-884-5600 | |
Karen Tal Woolman, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5627 | |
Mrs. Elise Ney, M.A, CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 4910 Massachusetts Ave Nw, Ste 29, Washington, DC 20016 Phone: 202-362-4300 | |
Ashley King, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2300 M St Nw, Washington, DC 20037 Phone: 410-991-4749 | |
Dr. Claire Bernstein, PH.D Audiologist Medicare: Not Enrolled in Medicare Practice Location: 800 Florida Ave Ne, Washington, DC 20002 Phone: 301-509-0722 | |
Hearing 4life Inc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3301 New Mexico Ave Nw Ste 125, Washington, DC 20016 Phone: 202-621-6374 | |
Kelsey Ann Ambrose, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2300 M St Nw Fl 4, Washington, DC 20037 Phone: 202-741-3275 |